Managing complex conditions with compassionate care

Clinical excellence

Our experienced infusion specialty care teams work to develop a customized care plan alongside on-going clinical monitoring to manage the progression of neurological disorders like ALS/Lou Gehrig’s disease and Duchenne Muscular Dystrophy. This personalized approach to care and dedicated team of specialists ensure infusion treatments are modified as needed to slow muscular dystrophy and atrophy. 

National reach with a local touch

As the largest independent infusion therapy provider in the United States, Option Care Health has the national reach and experience to provide a wider access of infusion treatments to the patients who need them most. Options for care at home or at infusion suites provide families and patients the opportunity to seamlessly transition care as needed.


Comprehensive infusion therapy care

We surround families and patients throughout their infusion therapy treatments with seamless support every step of the way

Every patient deserves safe, individualized care

Our clinical team customizes treatment plans to suit the specific needs of each patient with an assigned nurse and pharmacist to monitor treatment.

Clinical monitoring and reporting

Progress reports enable prescribers to remain informed on their patient’s status throughout their infusion treatment.

Exclusive and preferred access to pharmaceuticals

Option Care Health’s pharmaceutical partnerships give providers and patients access to several limited distribution treatments including Radicava®[*]Radicava is registered and owned by Mitsubishi Tanabe Pharma America, Inc. and Exondys®[*]Exondys is registered and owned by Sarepta Therapeutics, Inc.

Personalized coordination

Our comprehensive services coordinate care from hospital to home.

24/7/365 access to patient support

Experienced clinicians and nurses are always available by phone to answer questions and provide support for patients, families and providers.

Experts in infusion therapy care


number of states licensed to treat patients[*]January-December 2019 patient satisfaction data. Survey of 9,878 patients.


overall patient satisfaction[*]January-December 2019 patient satisfaction data. Survey of 9,878 patients.


infusion full service pharmacies[*]Data on file, Option Care Health.


multidisciplinary clinicians[*]Data on file, Option Care Health.